Pharmacotherapy- "Anti Drug" Vaccination

[Deborah]

WOW !! Wondering how this might effect the children already taking kiddy cocaine (ritalin)?

FOR IMMEDIATE RELEASE: MONDAY, JULY 26, 2004

UK GOVERNMENT REVEALS PLANS TO VACCINATE CHILDREN
AGAINST DRUGS :eek:

Children may be "vaccinated" against the effects of cocaine and other drugs in a plan recently revealed by the UK government, reports the well-regarded British newspaper, The Independent.  The article explains that "Doctors would immunize children at risk of becoming smokers or drug users with an injection" and that the program would operate in a way similar to the "current
nationwide measles, mumps and rubella vaccination
programme." Further, the authors reveal that "such
vaccinations are being developed by pharmaceutical
companies and are due to hit the market within two
years."

Earlier this month, the US-based Center for Cognitive Liberty & Ethics published a relevant and timely report, which addresses the imminent emergence of these same "pharmacotherapy" drugs into the US market.
 Among other well-documented information, the report notes that the US National Institute on Drug Abuse (NIDA) has allocated $12 million dollars to Xenova, the UK-based pharmaceutical company running trials on the "anti-cocaine" vaccine mentioned in the article.

The plan currently being researched and debated in the UK is therefore of concern to those monitoring trends in US drug policy.  The CCLE's policy report, "Pharmacotherapy and the Future of the Drug War" is the first publication to address the ethical and legal dimensions of this new breed of pharmaceuticals.  The report acknowledges potential benefits if these drugs
are used voluntarily, but warns that coercive or
compulsory use of such drugs to "immunize" drug
abusers or "at risk" potential users would violate a number of legal rights and trample the fundamental human right to freedom of thought.  

Richard Glen Boire, a legal scholar at the CCLE,
believes that vaccinating children with "anti-drug" drugs would be "alarming and unlawful, and would signal the first time that  neuropharmaceuticals were overtly used to enforce government policy."

Aside from the human rights concerns, the UK plan
raises serious health questions regarding the
long-term effects of these drugs on the complex
neurochemistry of the brain.  

The CCLE pharmacotherapy report directly addresses the potential legal and health consequences of US implementation of a  compulsory "anti-drug" vaccination program, which now seems closer to reality than ever before in light of the UK government's recent
announcement.

Copies of the CCLE's "Pharmacotherapy and the Future of the Drug War" can be obtained at
http://www.cognitiveliberty.org/issues/ ... erapy.html


To view the original article in The Independent (25 July 2004):
http://news.independent.co.uk/uk/crime/ ... ory=544439

For more information, or to speak with the authors of the report, please contact: Stephanie Anderson, Communications & Publications Coordinator Center for Cognitive Liberty & Ethics (CCLE) Phone/Fax:
530-750-7912 E-mail http://www.cognitiveliberty.org

PO Box 73481 Davis, California 95617 United States

FAIR USE NOTICE    
This email contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. I am making
such material available in my efforts to advance
understanding of environmental, political, human rights, economic, democracy,scientific, and social justice issues, etc.

[Deborah]

Hey, males with lactating breasts, diabetes, risk of stroke or some other fatal complication. Not such a bad trade-off, huh? I think I'd rather have "schizophrenia and other types of psychotic disorders".

http://keyetv.com/siteSearch/health_sto ... 20314.html

Drug Maker Acknowledges Misleading Statements

Jul 24, 2004 5:34 pm US/Central
TRENTON (AP) The maker of a popular medicine for schizophrenia has notified doctors that it minimized potentially fatal safety risks and made misleading claims about the drug in promotional materials.

Janssen Pharmaceutica Products sent a two-page letter to the health care community this past week to clarify the risks of Risperdal, Carol Goodrich, a spokeswoman for the Johnson & Johnson subsidiary, said Saturday.

The letter stems from a directive issued last year by the Food and Drug Administration, which told several makers of anti-psychotic drugs to update their product labels.

Janssen complied in November 2003, but the FDA determined that the company's promotional materials still minimized the risk of strokes, diabetes and other potentially fatal complications. The agency also said Janssen made misleading claims that the medication was safer in treating mental illness than similar drugs.

The Miami Herald reported Saturday that a handful of boys in Florida developed lactating breasts after taking Risperdal.

The drug, which is prescribed to more than 10 million people worldwide, was cited in a federal lawsuit filed earlier this month by a doctor who claims children have been harmed and even killed by the misuse of drugs he blames on aggressive marketing by drug manufacturers.

"The FDA did not think we had (initially) provided enough information, so that is why further notification was done," Goodrich said.

Risperdal is the leading drug used to combat schizophrenia and other types of psychotic disorders, earning Janssen about $2.1 billion in annual sales. The drug was first marketed about eight years ago.


(© 2004 The Associated Press. All Rights Reserved. This material may not be published, broadcast, rewritten, or redistributed. )